Extracellular vesicles in anti-tumor immunity - Vergani, Elisabetta; Daveri, Elena; Vallacchi, Viviana; Bergamaschi, Laura; Lalli, Luca; Castelli, Chiara; Rodolfo, Monica; Rivoltini, Licia; Huber, Veronica; (Seminars In Cancer Biology, 2022)

A Microsatellite in the Coding Sequence of HLA-A/B Is a Mutation Hotspot in Colon Cancer With Microsatellite Instability - Raab WJ, Mazzocchi A, Radice P, Sahoo D, Castelli C, Dalerba P, Colon Cancer Immunology; Immunotherapy (CCII) study group (Gastroenterology, 2022)

Back to simplicity: A four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients - Huber V; Di Guardo L; Lalli L; Giardiello D; Cova A; Squarcina P; Frati P; Di Giacomo AM; Pilla L; Tazzari M; Camisaschi C; Arienti F; et al. (Journal For Immunotherapy Of Cancer, 2021)

microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy - Daveri E; Vergani E; Shahaj E; Bergamaschi L; La Magra S; Dosi M; Castelli C; Rodolfo M; Rivoltini L; Vallacchi V; Huber V (Frontiers in Immunology, 2020)

Soledad, bienestar y salud en poblacion general española - Leal Leturia, Itziar (Investigador/a); CASTELLETTI, CHIARA (Investigador/a); Miret Garcia, Marta (Investigador principal (IP)); Martin Maria, Natalia (Investigador/a); MORENO AGOSTINO, DARIO (Investigador/a) (2020)

Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response - Pantaleo, Maria A.; Tarantino, Giuseppe; Agostinelli, Claudio; Urbini, Milena; Nannini, Margherita; Saponara, Maristella; Castelli, Chiara; Stacchiotti, Silvia; Fumagalli, Elena; Gatto, Lidia; Santini, Donatella; De Leo, Antonio; et al. (OncoImmunology, 2019)

Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial - Stacchiotti S; Ferrari S; Redondo A; Hindi-Muniz N; Palmerini E; Vaz Salgado MA; Frezza AM; Casali PG; Gutierrez A; Lopez-Pousa A; Grignani G; Italiano A; et al. (LANCET ONCOLOGY, 2019)

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk - Fortunato O; Borzi C; Milione M; Centonze G; Conte D; Boeri M; Verri C; Moro M; Facchinetti F; Andriani F; Roz L; Caleca L; et al. (INTERNATIONAL JOURNAL OF CANCER, 2019)

Immunosuppressive circuits in tumor microenvironment and their influence on cancer treatment efficacy - Tuccitto A; Shahaj E; Vergani E; Ferro S; Huber V; Rodolfo M; Castelli C; Rivoltini L; Vallacchi V (VIRCHOWS ARCHIV, 2019)

Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease - Ponziani FR; Bhoori S; Castelli C; Putignani L; Rivoltini L; Del Chierico F; Sanguinetti M; Morelli D; Paroni Sterbini F; Petito V; Reddel S; Calvani R; et al. (Hepatology, 2019)

Immune landscape and in vivo immunogenicity of NY-ESO-1 tumor antigen in advanced neuroblastoma patients 11 Medical and Health Sciences 1107 Immunology - Camisaschi C; Renne SL; Beretta V; Rini F; Spagnuolo RD; Tuccitto A; Podda MG; Parmiani G; Rivoltini L; Collini P; Castelli C; Luksch R (BMC CANCER, 2018)

Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases - Le Noci V; Guglielmetti S; Arioli S; Camisaschi C; Bianchi F; Sommariva M; Storti C; Triulzi T; Castelli C; Balsari A; Tagliabue E; Sfondrini L (Cell Reports, 2018)

pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma - Kuchuk O; Tuccitto A; Citterio D; Huber V; Camisaschi C; Milione M; Vergani B; Villa A; Alison MR; Carradori S; Supuran CT; Rivoltini L; et al. (Oncoimmunology, 2018)

Complex immune contextures characterise malignant peritoneal mesothelioma: Loss of adaptive immunological signature in the more aggressive histological types - Tazzari M; Brich S; Tuccitto A; Bozzi F; Beretta V; Spagnuolo R; Negri T; Stacchiotti S; Deraco M; Baratti D; Camisaschi C; Villa A; et al. (Journal of Immunology Research, 2018)

Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation - Huber V; Camisaschi C; Berzi A; Ferro S; Lugini L; Triulzi T; Tuccitto A; Tagliabue E; Castelli C; Rivoltini L (SEMINARS IN CANCER BIOLOGY, 2017)

Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment - Tazzari, Marcella; Indio, Valentina; Vergani, Barbara; De Cecco, Loris; Rini, Francesca; Negri, Tiziana; Camisaschi, Chiara; Fiore, Marco; Stacchiotti, Silvia; Dagrada, G. Paolo; Casali, Paolo G.; Gronchi, Alessandro; et al. (JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017)

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response - Vallacchi, Viviana; Camisaschi, Chiara; Dugo, Matteo; Vergani, Elisabetta; Deho, Paola; Gualeni, Ambra; Huber, Veronica; Gloghini, Annunziata; Maurichi, Andrea; Santinami, Mario; Sensi, Marialuisa; Castelli, Chiara; et al. (Genes, 2016)

Targeting immune regulatory networks to counteract immune suppression in cancer - Camisaschi C; Vallacchi V; Vergani E; Tazzari M; Ferro S; Tuccitto A; Kuchuk O; Shahaj E; Sulsenti R; Castelli C; Rodolfo M; Rivoltini L; et al. (Vaccines, 2016)

Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells - Tuccitto, Alessandra; Tazzari, Marcella; Beretta, Valeria; Rini, Francesca; Miranda, Claudia; Greco, Angela; Santinami, Mario; Patuzzo, Roberto; Vergani, Barbara; Villa, Antonello; Manenti, Giacomo; Cleris, Loredana; et al. (Stem Cells, 2016)

Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss - Stacchiotti, Silvia; Astolfi, Annalisa; Gronchi, Alessandro; Fontana, Andrea; Pantaleo, Maria A.; Negri, Tiziana; Brenca, Monica; Tazzari, Marcella; Urbini, Milena; Indio, Valentina; Colombo, Chiara; Radaelli, Stefano; et al. (MOLECULAR CANCER RESEARCH, 2016)

Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP) - Stacchiotti, Silvia; Pantaleo, Maria A.; Negri, Tiziana; Astolfi, Annalisa; Tazzari, Marcella; Dagrada, Gian Paolo; Urbini, Milena; Indio, Valentina; Maestro, Roberta; Gronchi, Alessandro; Fiore, Marco; Dei Tos, Angelo P.; et al. (CLINICAL CANCER RESEARCH, 2016)

Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours - Spagnuolo, Rosalin D.; Brich, Silvia; Bozzi, Fabio; Conca, Elena; Castelli, Chiara; Tazzari, Marcella; Maestro, Roberta; Brenca, Monica; Gualeni, Ambra V.; Gloghini, Annunziata; Stacchiotti, Silvia; Pierotti, Marco A.; et al. (Oncotarget, 2016)

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report - Tazzari, Marcella; Palassini, Elena; Vergani, Barbara; Villa, Antonello; Rini, Francesca; Negri, Tiziana; Colombo, Chiara; Crippa, Flavio; Morosi, Carlo; Casali, Paolo G.; Pilotti, Silvana; Stacchiotti, Silvia; et al. (BMC CANCER, 2015)

Dose-finding/phase II trial: bevacizumab, immunotherapy, and chemotherapy (BIC) in metastatic renal cell cancer (mRCC). Antitumor effects and variations of circulating T regulatory cells (Treg) - Donini, M.; Buti, S.; Lazzarelli, S.; Bozzetti, R.; Rivoltini, L.; Camisaschi, C.; Castelli, C.; Bearz, A.; Simonelli, C.; Lo Re, G.; Mattioli, R.; Caminiti, C.; et al. (Targeted Oncology, 2015)

Consensus nomenclature for CD8(+) T cell phenotypes in cancer - Apetoh, Lionel; Smyth, Mark J.; Drake, Charles G.; Abastado, Jean-Pierre; Apte, Ron N.; Ayyoub, Maha; Blay, Jean-Yves; Bonneville, Marc; Butterfield, Lisa H.; Caignard, Anne; Castelli, Chiara; Cavallo, Federica; et al. (Oncoimmunology, 2015)

Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies - Castelli, Chiara; Rivoltini, Licia; Rodolfo, Monica; Tazzari, Marcella; Belgiovine, Cristina; Allavena, Paola; (CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015)

?Cancer Bio-Immunotherapy in Siena?: Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17?19, 2013 - Maio M; Nicolay HJM; Cutaia O; Fonsatti E; Parmiani G; Trajanoski Z; Sahin U; Dellabona P; Jachetti E; Maccalli C; Adelchi Ruffini P; Bellone M; et al. (CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015)

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity - Castelli, Chiara; Triebel, Frederic; Rivoltini, Licia; Camisaschi, Chiara; (OncoImmunology, 2014)

TCR(+)CD4(-)CD8(-) T cells in Antigen-specific MHC Class I-restricted T-cell Responses After Allogeneic Hematopoietic Stem Cell Transplantation - Ahmed, Raija K.; Poiret, Thomas; Ambati, Aditya; Rane, Lalit; Remberger, Mats; Omazic, Birgitta; Vudattu, Nalini K.; Winiarski, Jacek; Ernberg, Ingemar; Axelsson-Robertson, Rebecca; Magalhaes, Isabelle; Castelli, Chiara; et al. (JOURNAL OF IMMUNOTHERAPY, 2014)

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment - Camisaschi, Chiara; Vallacchi, Viviana; Castelli, Chiara; Rivoltini, Licia; Rodolfo, Monica; (Expert Review Of Molecular Diagnostics, 2014)

Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3 - Camisaschi, Chiara; De Filippo, Annamaria; Beretta, Valeria; Vergani, Barbara; Villa, Antonello; Vergani, Elisabetta; Santinami, Mario; Cabras, Antonello Domenico; Arienti, Flavio; Triebel, Frederic; Rodolfo, Monica; Rivoltini, Licia; et al. (JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014)

Immune response markers in sentinel nodes may predict melanoma progression - Rodolfo, Monica; Castelli, Chiara; Rivoltini, Licia; (OncoImmunology, 2014)

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy - Tazzari, M.; Negri, T.; Rini, F.; Vergani, B.; Huber, V.; Villa, A.; Dagrada, P.; Colombo, C.; Fiore, M.; Gronchi, A.; Stacchiotti, S.; Casali, P. G.; et al. (BRITISH JOURNAL OF CANCER, 2014)

Transcriptional Profiling of Melanoma Sentinel Nodes Identify Patients with Poor Outcome and Reveal an Association of CD30(+) T Lymphocytes with Progression - Vallacchi, Viviana; Vergani, Elisabetta; Camisaschi, Chiara; Deho, Paola; Cabras, Antonello D.; Sensi, Marialuisa; De Cecco, Loris; Bassani, Niccolo; Ambrogi, Federico; Carbone, Antonino; Crippa, Federica; Vergani, Barbara; et al. (CANCER RESEARCH, 2014)

Monitoring the Frequency and Function of Regulatory T Cells and Summary of the Approaches Currently Used to Inhibit Regulatory T Cells in Cancer Patients - Camisaschi, Chiara; Tazzari, Marcella; Rivoltini, Licia; Castelli, Chiara; (Methods in Molecular Biology, 2014)

Classification of current anticancer immunotherapies - Galluzzi L; Vacchelli E; Bravo-San Pedro JM; Buqué A; Senovilla L; Baracco EE; Bloy N; Castoldi F; Abastado JP; Agostinis P; Apte RN; Aranda F; et al. (Oncotarget, 2014)

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma - Castelli, Chiara; Tazzari, Marcella; Negri, Tiziana; Vergani, Barbara; Rivoltini, Licia; Stacchiotti, Silvia; Pilotti, Silvana; (Journal of Translational Medicine, 2013)

Effects of cyclophosphamide and IL-2 on regulatory CD4(+) T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response - Camisaschi, Chiara; Filipazzi, Paola; Tazzari, Marcella; Casati, Chiara; Beretta, Valeria; Pilla, Lorenzo; Patuzzo, Roberto; Maurichi, Andrea; Cova, Agata; Maio, Michele; Chiarion-Sileni, Vanna; Tragni, Gabrina; et al. (Cancer Immunology Immunotherapy, 2013)

Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides - Filipazzi, Paola; Pilla, Lorenzo; Mariani, Luigi; Patuzzo, Roberto; Castelli, Chiara; Camisaschi, Chiara; Maurichi, Andrea; Cova, Agata; Rigamonti, Gianluigi; Giardino, Felicetta; Di Florio, Annabella; Asioli, Marco; et al. (CLINICAL CANCER RESEARCH, 2012)

Don't run before you can walk - Rivoltini, Licia; Marrari, Andrea; Castelli, Chiara; Villa, Sergio; Valdagni, Riccardo; (Nature Reviews Urology, 2012)

Frequency of Circulating Tregs with Demethylated FOXP3 Intron 1 in Melanoma Patients Receiving Tumor Vaccines and Potentially Treg-Depleting Agents - de Vries, I. Jolanda M.; Castelli, Chiara; Huygens, Caroline; Jacobs, Joannes F. M.; Stockis, Julie; Schuler-Thurner, Beatrice; Adema, Gosse J.; Punt, Cornelis J. A.; Rivoltini, Licia; Schuler, Gerold; Coulie, Pierre G.; Lucas, Sophie; (CLINICAL CANCER RESEARCH, 2011)

Spheres of Influence in Cancer Stem Cell Biology - Perego, Michela; Alison, Malcolm R.; Mariani, Luigi; Rivoltini, Licia; Castelli, Chiara; (JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011)

Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009 - Maio M, Nicolay HJ, Ascierto PA, Belardelli F, Camerini R, Colombo MP, Queirolo P, Ridolfi R, Russo V, Fonsatti E, Parmiani G, NIBIT (CANCER IMMUNOLOGY IMMUNOTHERAPY, 2010)

Heterogeneous Phenotype of Human Melanoma Cells with In Vitro and In Vivo Features of Tumor-Initiating Cells - Perego, Michela; Tortoreto, Monica; Tragni, Gabrina; Mariani, Luigi; Deho, Paola; Carbone, Antonino; Santinami, Mario; Patuzzo, Roberto; Della Mina, Pamela; Villa, Antonello; Pratesi, Graziella; Cossa, Giacomo; et al. (JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010)

LAG-3 Expression Defines a Subset of CD4(+)CD25(high)Foxp3(+) Regulatory T Cells That Are Expanded at Tumor Sites - Camisaschi, Chiara; Casati, Chiara; Rini, Francesca; Perego, Michela; De Filippo, Annamaria; Rini, Frederic; Parmiani, Giorgio; Belli, Filiberto; Rivoltini, Licia; Castelli, Chiara; (JOURNAL OF IMMUNOLOGY, 2010)

Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity? - Iero, Manuela; Filipazzi, Paola; Castelli, Chiara; Belli, Filiberto; Valdagni, Riccardo; Parmiani, Giorgio; Patuzzo, Roberto; Santinami, Mario; Rivoltini, Licia; (Cancer Immunology Immunotherapy, 2009)

Inhibition of Serine-Peptidase Activity Enhances the Generation of a Survivin-Derived HLA-A2-Presented CTL Epitope in Colon-Carcinoma Cells - Preta, G.; Marescotti, D.; Fortini, C.; Carcoforo, P.; Castelli, C.; Masucci, M.; Gavioli, R.; (SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2008)

Induction of Both CD8(+) and CD4(+) T-Cell - Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1 - Maccalli, Cristina; Di Cristanziano, Veronica; Fodale, Valentina; Corsi, Domenico; D'Agostino, Giuseppina; Petrangeli, Valentina; Laurenti, Luca; Guida, Sofia; Mazzocchi, Arabella; Arienti, Flavio; Perrone, Maria P.; Castelli, Chiara; et al. (CLINICAL CANCER RESEARCH, 2008)

Human Plasmacytoid Dendritic Cells Interact with gp96 via CD91 and Regulate Inflammatory Responses - De Filippo, AnnaMaria; Binder, Robert J.; Camisaschi, Chiara; Beretta, Valeria; Arienti, Flavio; Villa, Antonello; Della Mina, Pamela; Parmiani, Giorgio; Rivoltini, Licia; Castelli, Chiara; (JOURNAL OF IMMUNOLOGY, 2008)

Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activation - Casati, Chiara; Camisaschi, Chiara; Novellino, Luisa; Mazzocchi, Arabella; Triebel, Fredrric; Rivoltini, Licia; Parmiani, Giorgio; Castelli, Chiara; (JOURNAL OF IMMUNOLOGY, 2008)

PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cells - Novellino, Luisa; De Filippo, Annamaria; Deho, Paola; Perrone, Federica; Pilotti, Silvana; Parmiani, Giorgio; Castelli, Chiara; (CELLULAR SIGNALLING, 2008)

NKG2D-Mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patients - Maccalli, Cristina; Nonaka, Daisuke; Piris, Adriano; Pende, Daniela; Rivoltini, Licia; Castelli, Chiara; Parmiani, Giorgio; (CLINICAL CANCER RESEARCH, 2007)

Transforming growth factor-beta signaling and regulatory T cells - Reply - Filipazzi, Paola; Castelli, Chiara; Roberta, Valenti; Huber, Veronica; Iero, Manuela; Pilla, Lorenzo; Rivoltini, Licia; Parmiani, Giorgio; (JOURNAL OF CLINICAL ONCOLOGY, 2007)

Universal and stemness-related tumor antigens: Potential use in cancer immunotherapy - Parmiani, Giorgio; Russo, Vincenzo; Marrari, Andrea; Cutolo, Gianluca; Casati, Chiara; Pilla, Lorenzo; Maccalli, Cristina; Rivoltini, Licia; Castelli, Chiara; (CLINICAL CANCER RESEARCH, 2007)

Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine - Filipazzi, Paola; Valenti, Roberta; Huber, Veronica; Pilla, Lorenzo; Canese, Paola; Iero, Manuela; Castelli, Chiara; Mariani, Luigi; Parmiani, Giorgio; Rivoltini, Licia; (Journal Of Clinical Oncology, 2007)

Phenotypic characterization of human colorectal cancer stem cells - Dalerba, Piero; Dylla, Scott J.; Park, In-Kyung; Liu, Rui; Wang, Xinhao; Cho, Robert W.; Hoey, Timothy; Gurney, Austin; Huang, Emina H.; Simeone, Diane M.; Shelton, Andrew A.; Parmiani, Giorgio; et al. (Proceedings Of The National Academy Of Sciences Of The United States Of America, 2007)

Melanoma immunology: past, present and future - Parmiani, Giorgio; Castelli, Chiara; Santinami, Mario; Rivoltini, Licia; (CURRENT OPINION IN ONCOLOGY, 2007)

Unique human tumor antigens: Immunobiology and use in clinical trials - Parmiani, Giorgio; De Filippo, Annamaria; Novellino, Luisa; Castelli, Chiara; (JOURNAL OF IMMUNOLOGY, 2007)

Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients - Parmiani, G.; Castelli, C.; Pilla, L.; Santinami, M.; Colombo, M. P.; Rivoltini, L.; (ANNALS OF ONCOLOGY, 2007)

Heat shock proteins gp96 as immunogens in cancer patients - Parmiani, Giorgio; De Filippo, Annamaria; Pilla, Lorenzo; Castelli, Chiara; Rivoltini, Licia; (International Journal Of Hyperthermia, 2006)

Soluble human LAG-3 molecule amplifies the in vitro generation of type 1 tumor-specific immunity - Casati, C; Camisaschi, C; Rini, F; Arienti, F; Rivoltini, L; Triebel, F; Parmiani, G; Castelli, C; (CANCER RESEARCH, 2006)

Erratum: Immune mechanisms in neoplasia (Drug Discovery Today: Disease Mechanisms (2004) vol. 1 (3) (375-381) 10.1016/j.ddmec.2004.11.007) - Castelli C; Dalerba P; Casati C; Novellino L; Parmiani G; De Filippo A (Drug Discovery Today: Disease Mechanisms, 2005)

Chemokine receptor 7, a new player in regulating apoptosis of CD8(+) T cells in cancer patients - Parmiani, G; Castelli, C; Rivoltini, L; (CLINICAL CANCER RESEARCH, 2005)

Natural killer and NK-Like T-Cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96 - Pilla, L; Squarcina, P; Coppa, J; Mazzaferro, V; Huber, V; Pende, D; Maccalli, C; Sovena, G; Mariani, L; Castelli, C; Parmiani, G; Rivoltini, L; (CANCER RESEARCH, 2005)

Escape strategies and reasons for failure in the interaction between tumour cells and the immune system: how can we tilt the balance towards immune-mediated cancer control? - Rivoltini, L; Canese, P; Huber, V; Iero, M; Pilla, L; Valenti, R; Fais, S; Lozupone, F; Casati, C; Castelli, C; Parmiani, G; (EXPERT OPINION ON BIOLOGICAL THERAPY, 2005)

Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: Evidence against immortality as a constitutive trait of tumor cells - Dalerba, P; Guiducci, C; Poliani, PL; Cifola, I; Parenza, M; Frattini, M; Gallino, G; Carnevali, I; Di Giulio, I; Andreola, S; Lombardo, C; Rivoltini, L; et al. (CANCER RESEARCH, 2005)

A listing of human tumor antigens recognized by T cells: March 2004 update - Novellino, L; Castelli, C; Parmiani, G; (Cancer Immunology Immunotherapy, 2005)

Heat shock proteins and their use as anticancer vaccines - Parmiani, G; Testori, A; Maio, M; Castelli, C; Rivoltini, L; Pilla, L; Belli, F; Mazzaferro, V; Coppa, J; Patuzzo, R; Sertoli, MR; Hoos, A; et al. (CLINICAL CANCER RESEARCH, 2004)

Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer - Castelli, C; Rivoltini, L; Rini, F; Belli, F; Testori, A; Maio, M; Mazzaferro, V; Coppa, J; Srivastava, PK; Parmiani, G; (Cancer Immunology Immunotherapy, 2004)

Effect of human natural killer and gamma delta T cells on the growth of human autologous melanoma xenografts in SCID mice - Lozupone, F; Pende, D; Burgio, VL; Castelli, C; Spada, M; Venditti, M; Luciani, F; Lugini, L; Federici, C; Ramoni, C; Rivoltini, L; Parmiani, G; et al. (CANCER RESEARCH, 2004)

Immune mechanisms in neoplasia - Castelli C; Dalerba P; Casati C; Novellino L; Parmiani G; De Filippo A (Drug Discovery Today: Disease Mechanisms, 2004)

Potent phagocytic activity discriminates metastatic and primary human malignant melanomas: A key role of ezrin - Lugini, L; Lozupone, F; Matarrese, P; Funaro, C; Luciani, F; Malorni, W; Rivoltini, L; Castelli, C; Tinari, A; Piris, A; Parmiani, G; Fais, S; (LABORATORY INVESTIGATION, 2003)

Antigen-specific immunity in neuroblastoma patients: Antibody and T-cell recognition of NY-ESO-1 tumor antigen - Rodolfo, M; Luksch, R; Stockert, E; Chen, YT; Collini, P; Ranzani, T; Lombardo, C; Dalerba, P; Rivoltini, L; Arienti, F; Fossati-Bellani, F; Old, LJ; et al. (CANCER RESEARCH, 2003)

Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells - Rivoltini, L; Castelli, C; Carrabba, M; Mazzaferro, V; Pilla, L; Huber, V; Coppa, J; Gallino, G; Scheibenbogen, C; Squarcina, P; Cova, A; Camerini, R; et al. (JOURNAL OF IMMUNOLOGY, 2003)

The apoptosis inhibitor protein survivin induces tumor-specific CD8(+) and CD4(+) T cells in colorectal cancer patients - Casati, C; Dalerba, P; Rivoltini, L; Gallino, G; Deho, P; Rini, F; Belli, F; Mezzanzanica, D; Costa, A; Andreola, S; Leo, E; Parmiani, G; et al. (CANCER RESEARCH, 2003)

NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activity - Maccalli, C; Pende, D; Castelli, C; Mingari, MC; Robbins, PF; Parmiani, G; (EUROPEAN JOURNAL OF IMMUNOLOGY, 2003)

Identification of a mutated receptor-like protein tyrosine phosphatase kappa as a novel, class IIHLA-restricted melanoma antigen - Novellino, L; Renkvist, N; Rini, F; Mazzocchi, A; Rivoltini, L; Greco, A; Deho, P; Squarcina, P; Robbins, PF; Parmiani, G; Castelli, C; (JOURNAL OF IMMUNOLOGY, 2003)

Vaccination of patients with solid tumours - Parmiani, G; Pilla, L; Castelli, C; Rivoltini, L; (ANNALS OF ONCOLOGY, 2003)

Suboptimal activation of CD8(+) T cells by melanoma-derived altered peptide ligands: Role of melan-A/MART-1 optimized analogues - Carrabba, MG; Castelli, C; Maeurer, MJ; Squarcina, P; Cova, A; Pilla, L; Renkvist, N; Parmiani, G; Rivoltini, L; (CANCER RESEARCH, 2003)

Immunology and immunotherapy of colorectal cancer - Dalerba, P; Maccalli, C; Casati, C; Castelli, C; Parmiani, G; (CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003)

Immunotherapy of melanoma - Parmiani, G; Castelli, C; Rivoltini, L; Casati, C; Tully, GA; Novellino, L; Patuzzo, A; Tosi, D; Anichini, A; Santinami, M; (SEMINARS IN CANCER BIOLOGY, 2003)

Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction - Rivoltini, L; Carrabba, M; Huber, V; Castelli, C; Novellino, L; Dalerba, P; Mortarini, R; Arancia, G; Anichini, A; Fais, S; Parmiani, G; (Immunological Reviews, 2002)

T-cell response to unique and shared antigens and vaccination of cancerpatients - Parmiani G; Sensi M; Castelli C; Rivoltini L; Anichini A (Cancer Immunity, 2002)

Cancer immunotherapy with peptide-based vaccines: What have we achieved? - Where are we going? - Parmiani, G; Castelli, C; Dalerba, P; Mortarini, R; Rivoltini, L; Marincola, FM; Anichini, A; (JNCI-Journal of the National Cancer Institute, 2002)

Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles - Andreola, G; Rivoltini, L; Castelli, C; Huber, V; Perego, P; Deho, P; Squarcina, P; Accornero, P; Lozupone, F; Lugini, L; Stringaro, A; Molinari, A; et al. (JOURNAL OF EXPERIMENTAL MEDICINE, 2002)

Peptide-specific CD8+T-cell evolution in vivo: Response to peptide vaccination with Melan-A/MART-I - Jager, E; Hohn, H; Necker, A; Forster, R; Karbach, J; Freitag, K; Neukirch, C; Castelli, C; Salter, RD; Knuth, A; Maeurer, MJ; (INTERNATIONAL JOURNAL OF CANCER, 2002)

Impact of antigen presentation on TCR modulation and cytokine release: Implications for detection and sorting of antigen-specific CD8(+) T cells using HLA-A2 wild-type or HLA-A2 mutant tetrameric complexes - Jager, E; Salter, R; Castelli, C; Hohn, H; Freitag, K; Karbach, J; Neukirch, C; Necker, A; Knuth, A; Maeurer, MJ; (JOURNAL OF IMMUNOLOGY, 2002)

The T-Cell response in patients with cancer - Castelli, C; Maeurer, MJ; (Advances in Cancer Research, 2002)

Cancer risk in persons receiving prescriptions for paracetamol: A Danish cohort study - Friis, S; Nielsen, GL; Mellemkjaer, L; McLaughlin, JK; Thulstrup, AM; Blot, WJ; Lipworth, L; Vilstrup, H; Olsen, JH; (INTERNATIONAL JOURNAL OF CANCER, 2002)

Improved detection of melanoma antigen-specific T cells expressing low or high levels of CD8 by HLA-A2 tetramers presenting a Melan-A/MART-1 peptide analogue - Maeurer M; Necker A; Salter R; Castelli C; Höhn H; Karbach J; Freitag K; Neukirch C; Knuth A; Jäger E (INTERNATIONAL JOURNAL OF CANCER, 2002)

Antigen recognition by T cells: a strong sense of structure - Maeurer, M; Hohn, H; Castelli, C; Salter, RD; Necker, A; Reichert, T; Knuth, A; Jager, E; (TRENDS IN IMMUNOLOGY, 2001)

Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface - Hallermalm, K; Seki, K; Wei, CH; Castelli, C; Rivoltini, L; Kiessling, R; Levitskaya, J; (BLOOD, 2001)

Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells - Castelli, C; Ciupitu, AMT; Rini, F; Rivoltini, L; Mazzocchi, A; Kiessling, R; Parmiani, G; (CANCER RESEARCH, 2001)

Simultaneous transduction of B7-1 and IL-2 genes into human melanoma cells to be used as vaccine: enhancement of stimulatory activity for autologous and allogeneic lymphocytes - Mazzocchi, A; Melani, C; Rivoltini, L; Castelli, C; Del Vecchio, M; Lombardo, C; Colombo, MP; Parmiani, G; (CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001)

A listing of human tumor antigens recognized by T cells - Renkvist, N; Castelli, C; Robbins, PF; Parmiani, G; (CANCER IMMUNOLOGY IMMUNOTHERAPY, 2001)

T cell response to tumor antigens and its therapeutic use in cancer patients - Parmiani, G; Castelli, C; Dalerba, P; Rivoltini, L (Advances In Experimental Medicine And Biology, 2001)

T cell responses in colorectal cancer patients: Evidence for class IIHLA-restricted recognition of shared tumor-associated antigens - Bremers, AJA; Andreola, S; Leo, E; Gallino, F; Rini, F; Lombardo, C; Belli, F; Kuppen, PJK; Parmiani, G; Castelli, C (INTERNATIONAL JOURNAL OF CANCER, 2000)

T-cell recognition of melanoma-associated antigens - Castelli, C; Rivoltini, L; Andreola, G; Carrabba, M; Renkvist, N; Parmiani, G (JOURNAL OF CELLULAR PHYSIOLOGY, 2000)

Cytotoxic T lymphocytes define multiple peptide isoforms derived from the melanoma-associated antigen MART-1/Melan-A - Jager, E; Hohn, H; Karbach, J; Momburg, F; Castelli, C; Knuth, A; Seliger, B; Maeurer, MJ (INTERNATIONAL JOURNAL OF CANCER, 1999)

Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens - Castelli, C; Tarsini, P; Mazzocchi, A; Rini, F; Rivoltini, L; Ravagnani, F; Gallino, F; Belli, F; Parmiani, G; (JOURNAL OF IMMUNOLOGY, 1999)

A superagonist variant of peptide MART1/melan A(27-35) elicits anti-melanoma CD8(+) T cells with enhanced functional characteristics: Implication for more effective immunotherapy - Rivoltini, L; Squarcina, P; Loftus, DJ; Castelli, C; Tarsini, P; Mazzocchi, A; Rini, F; Viggiano, V; Belli, F; Parmiani, G; (CANCER RESEARCH, 1999)

Human melanoma-reactive CD4(+) and CD8(+) CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing - Rivoltini, L; Radrizzani, M; Accornero, P; Squarcina, P; Chiodoni, C; Mazzocchi, A; Castelli, C; Tarsini, P; Viggiano, V; Belli, F; Colombo, MP; Parmiani, G; (JOURNAL OF IMMUNOLOGY, 1998)

Peptides derived from self-proteins as partial agonists and antagonists of human CD8(+) T-cell clones reactive to melanoma/melanocyte epitope MART1(27-35) - Loftus, DJ; Squarcina, P; Nielsen, MB; Geisler, C; Castelli, C; Odum, N; Appella, E; Parmiani, G; Rivoltini, L; (CANCER RESEARCH, 1998)

Autologous human dendriphages pulsed with synthetic or natural tumor peptides elicit tumor-specific CTLs in vitro - Tjandrawan, T; Martin, DM; Maeurer, MJ; Castelli, C; Lotze, MT; Storkus, WJ; (J Immunother, 1998)

Immunogenicity of the ALLAVGATK (gp100(17-25)) peptide in HLA-A3.1 melanoma patients - Castelli, C; Mazzocchi, A; Rini, F; Tarsini, P; Rivoltini, L; Maio, M; Gallino, G; Belli, F; Parmiani, G (EUROPEAN JOURNAL OF IMMUNOLOGY, 1998)

Recognition of melanoma-derived antigens by CTL: Possible mechanisms involved in down-regulating anti-tumor T-cell reactivity - Rivoltini L; Loftus DJ; Squarcina P; Castelli C; Rini F; Arienti F; Belli F; Marincola FM; Geisler C; Borsatti A; Appella E; Parmiani G (Critical Reviews In Immunology, 1998)

Generation and phenotypic characterization of new human ovarian cancer cell lines with the identification of antigens potentially recognizable by HLA-restricted cytotoxic T cells - Ramakrishna, V; Negri, DRM; Brusic, V; Fontanelli, R; Canevari, S; Bolis, G; Castelli, C; Parmiani, G (INTERNATIONAL JOURNAL OF CANCER, 1997)

T-cell recognition of melanoma antigens and its therapeutic applications - Castelli, C; Rivoltini, L; Mazzocchi, A; Parmiani, G; (INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 1997)

New tumour-restricted melanoma antigens as defined by cytotoxic T-cell responses - Parmiani G; Anichini A; Castelli C (MELANOMA RESEARCH, 1997)

A possible role for epitope mimicry in shaping the CTL response to melanoma antigen MART-1 - Loftus, D; Castelli, C; Marincola, F; Parmiani, G; Appella, E; Rivoltini, L; (FASEB JOURNAL, 1996)

Tumor escape from immune recognition - Lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen - Maeurer, MJ; Gollin, SM; Martin, D; Swaney, W; Bryant, J; Castelli, C; Robbins, P; Parmiani, G; Storkus, WJ; Lotze, MT; (JOURNAL OF CLINICAL INVESTIGATION, 1996)

Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes - Mazzocchi, A; Storkus, WJ; Traversari, C; Tarsini, P; Maeurer, MJ; Rivoltini, L; Vegetti, C; Belli, F; Anichini, A; Parmiani, G; Castelli, C; (JOURNAL OF IMMUNOLOGY, 1996)

Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1(27-35) - Loftus, DJ; Castelli, C; Clay, TM; Squarcina, P; Marincola, FM; Nishimura, MI; Parmiani, G; Appella, E; Rivoltini, L; (JOURNAL OF EXPERIMENTAL MEDICINE, 1996)

Tumor escape from immune recognition: Loss of HLA-A2 melanoma cell surface expression is associated with a complex rearrangement of the short arm of chromosome 6 - Maeurer M; Gollin S; Storkus W; Swaney W; Karbach J; Martin D; Castelli C; Salter R; Knuth A; Lotze M (Clinical Cancer Research, 1996)

Differences in frequency distribution of HLA-A2 subtypes between North American and Italian white melanoma patients: Relevance for epitope specific vaccination protocols - Player, MA; Barracchini, KC; Simonis, TB; Rivoltini, L; Arienti, F; Castelli, C; Mazzocchi, A; Belli, F; Parmiani, G; Marincola, FM; (J IMMUNOTHER, 1996)

HOST IMMUNE-RESPONSE IN RENAL-CELL CANCER - INTERLEUKIN-4 (IL-4) AND IL-10 MESSENGER-RNA ARE FREQUENTLY DETECTED IN FRESHLY COLLECTED TUMOR-INFILTRATING LYMPHOCYTES - MAEURER, MJ; MARTIN, DM; CASTELLI, C; ELDER, E; LEDER, G; STORKUS, WJ; LOTZE, MT; (CANCER IMMUNOLOGY IMMUNOTHERAPY, 1995)

MASS-SPECTROMETRIC IDENTIFICATION OF A NATURALLY PROCESSED MELANOMA PEPTIDE RECOGNIZED BY CD8(+) CYTOTOXIC T-LYMPHOCYTES - CASTELLI, C; STORKUS, WJ; MAEURER, MJ; MARTIN, DM; HUANG, EC; PRAMANIK, BN; NAGABHUSHAN, TL; PARMIANI, G; LOTZE, MT; (JOURNAL OF EXPERIMENTAL MEDICINE, 1995)

EXPRESSION OF INTERLEUKIN-1-ALPHA, INTERLEUKIN-6, AND TUMOR-NECROSIS-FACTOR-ALPHA GENES IN HUMAN-MELANOMA CLONES IS ASSOCIATED WITH THAT OF MUTATED N-RAS ONCOGENE - CASTELLI, C; SENSI, M; LUPETTI, R; MORTARINI, R; PANCERI, P; ANICHINI, A; PARMIANI, G; (CANCER RESEARCH, 1994)

CYTOTOXIC T-LYMPHOCYTES RECOGNIZE TUMOR-ANTIGENS OF A MURINE COLONIC-CARCINOMA BY USING DIFFERENT T-CELL RECEPTORS - RODOLFO, M; CASTELLI, C; BASSI, C; ACCORNERO, P; SENSI, M; PARMIANI, G; (INTERNATIONAL JOURNAL OF CANCER, 1994)

T-CELL RECEPTOR (TCR) STRUCTURE OF AUTOLOGOUS MELANOMA REACTIVE CYTOTOXIC T-LYMPHOCYTE (CTL) CLONES - TUMOR-INFILTRATING LYMPHOCYTES OVEREXPRESS IN-VIVO THE TCR BETA-CHAIN SEQUENCE USED BY AN HLA-A2-RESTRICTED AND MELANOCYTE-LINEAGE SPECIFIC CTL CLONE - SENSI, M; SALVI, S; CASTELLI, C; MACCALLI, C; MAZZOCCHI, A; MORTARINI, R; NICOLINI, G; HERLYN, M; PARMIANI, G; ANICHINI, A; (JOURNAL OF EXPERIMENTAL MEDICINE, 1993)

USE OF THE V-DELTA-1 VARIABLE REGION IN THE FUNCTIONAL T-CELL RECEPTOR ALPHA-CHAIN OF A WT31+ CYTOTOXIC T-LYMPHOCYTE CLONE WHICH SPECIFICALLY RECOGNIZES HLA-A2 MOLECULE - CASTELLI, C; MAZZOCCHI, A; SALVI, S; ANICHINI, A; SENSI, M; (SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992)

INVOLVEMENT OF SOMATICALLY ACQUIRED ECOTROPIC VIRUSES IN THE IMMUNOGENICITY OF NUDE-TRANSPLANTED NIH/3T3 TRANSFORMED-CELL LINES - SENSI, M; BERGOMI, M; PANCERI, P; CASTELLI, C; LUPETTI, R; TRAVERSARI, C; CARBONE, G; PARMIANI, G; (JOURNAL OF IMMUNOLOGY, 1992)

EXPANSION OF MAJOR HISTOCOMPATIBILITY COMPLEX-RESTRICTED ANTIMELANOMA CYTOTOXIC T-CELL LYMPHOCYTE CLONES WITH IDENTICAL T-CELL RECEPTOR FROM TUMOR-INFILTRATING LYMPHOCYTES - SENSI, M; CASTELLI, C; SALVI, S; MAZZOCCHI, A; MORTARINI, R; NICOLINI, G; ANICHINI, A; PARMIANI, G; (J Immunother, 1992)

Recombinant interferon-? differently affects DQA and DRA gene expression in two human melanoma clones: Transcriptional and posttranscriptional regulation - Castelli C; Sensi M; Parmiani G (EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1991)

SELECTIVE PURGING BY HUMAN INTERLEUKIN-2 ACTIVATED LYMPHOCYTES OF BONE MARROWS CONTAMINATED WITH A LYMPHOMA LINE OR AUTOLOGOUS LEUKEMIC-CELLS - GAMBACORTIPASSERINI, C; RIVOLTINI, L; FIZZOTTI, M; RODOLFO, M; SENSI, ML; CASTELLI, C; ORAZI, A; POLLI, N; BREGNI, M; SIENA, S; BORIN, L; POGLIANI, E; et al. (BRITISH JOURNAL OF HAEMATOLOGY, 1991)

HUMAN ALLOGENEIC MELANOMA-REACTIVE T-HELPER LYMPHOCYTE CLONES - FUNCTIONAL-ANALYSIS OF LYMPHOCYTE-MELANOMA INTERACTIONS - RADRIZZANI, M; BENEDETTI, B; CASTELLI, C; LONGO, A; FERRARA, GB; HERLYN, M; PARMIANI, G; FOSSATI, G; (INTERNATIONAL JOURNAL OF CANCER, 1991)

Two autologous melanoma-specific and MHC-restricted human T cell clones with identical intra-tumour reactivity do not share the same TCR V? and V? gene families - Sensi M; Castelli C; Anichini A; Grossberger D; Mazzocchi A; Mortarini R; Parmiani G (MELANOMA RESEARCH, 1991)

H-2 CLASS-I GENE ANALYSIS IN 3-METHYLCHOLANTHRENE-INDUCED MURINE FIBROSARCOMAS - CASTELLI, C; MAZZUCCHELLI, F; SENSI, M; CARBONE, G; PARMIANI, G; (EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1990)

LYMPHOCYTES-T CAN MEDIATE LYSIS OF AUTOLOGOUS MELANOMA-CELLS BY MULTIPLE MECHANISMS - EVIDENCE WITH A SINGLE T-CELL CLONE - MAZZOCCHI, A; ANICHINI, A; CASTELLI, C; SENSI, M; POLI, F; RUSSO, C; PARMIANI, G; (CANCER IMMUNOLOGY IMMUNOTHERAPY, 1990)

P-GLYCOPROTEIN GENE AMPLIFICATION AND EXPRESSION IN MULTIDRUG-RESISTANT MURINE P388 AND B-16 CELL-LINES - CAPRANICO, G; DEISABELLA, P; CASTELLI, C; SUPINO, R; PARMIANI, G; ZUNINO, F; (BRITISH JOURNAL OF CANCER, 1989)

LOSS OF HETEROZYGOSITY OF DQ-ALPHA GENE IN HUMAN-MALIGNANT MELANOMA - CASTELLI, C; MAZZUCCHELLI, F; SENSI, M; FOSSATI, G; PARMIANI, G; (Tumori J, 1989)

DIFFERENTIAL SUSCEPTIBILITY TO RECOMBINANT INTERFERON-GAMMA-INDUCED HLA-DQ ANTIGEN MODULATION AMONG CLONES FROM A HUMAN METASTATIC MELANOMA - ANICHINI, A; CASTELLI, C; SOZZI, G; FOSSATI, G; PARMIANI, G; (JOURNAL OF IMMUNOLOGY, 1988)

LY-5.185 MOLECULE IS ASSOCIATED WITH THYMIC MATURATION OF LYMPHOCYTES BUT NOT WITH THEIR CYTOTOXIC ACTIVITY - TRAVERSARI, C; FERRARI, G; GRAZIOLI, L; BALLINARI, D; COLOMBO, MP; CASTELLI, C; PIEROTTI, MA; PARMIANI, G; (EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1987)

DISULFIDE-LINKED SURFACE MOLECULES OF MONOCLONAL ANTIGEN-SPECIFIC SUPPRESSOR T-CELLS - EVIDENCE FOR T-CELL RECEPTOR STRUCTURES - BALLINARI, D; CASTELLI, C; TRAVERSARI, C; PIEROTTI, MA; PARMIANI, G; PALMIERI, G; RICCIARDICASTAGNOLI, P; ADORNI, L; (EUROPEAN JOURNAL OF IMMUNOLOGY, 1985)

Expression of Interleukin la, Interleukin 6, and Tumor Necrosis Factor a Genes in Human Melanoma Clones Is Associated with That of Mutated N-RAS Oncogene - Castelli C; Sensi M; Lupetti R; Mortarini R; Panceri P; Anichini A; Parmiani G (CANCER RESEARCH, 1994)

RECOMBINANT INTERFERON-GAMMA DIFFERENTLY AFFECTS DQA AND DRA GENE-EXPRESSION IN 2 HUMAN-MELANOMA CLONES - TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION - CASTELLI, C; SENSI, M; PARMIANI, G; (EXPERIMENTAL AND CLINICAL IMMUNOGENETICS, 1991)

Connecting and feeling: Associations between social factors and emotions in nine countries - Castelletti, C; Lara, E; Tobiasz-Adamczyk, B; Koskinen, S; Olaya, B; Haro, JM; Leonardi, M; Kowal, P; Chatterji, S; Ayuso-Mateos, JL; Miret, M (International Journal Of Psychology, 2023)